TGF-β exhibits a paradoxical role in breast cancer pathogenesis: During early tumorigenesis, it exerts growth-suppressive effects on normal and premalignant mammary epithelium, whereas advanced malignancies develop resistance to these tumor-suppressive signals, enabling TGF-β to drive oncogenic progression (74). Here, TGFB1 is linked to breast carcinoma.